Multicenter Study to Evaluate the Impact of Evolocumab on Major Cardiovascular Events in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke
The purpose of this research study is to assess whether lowering of your cholesterol blood level can reduce your risk for major cardiovascular events (for example, heart attack or stroke) when evolocumab is taken in addition to your current medical therapy as directed by your doctor, which may include a medication for the treatment of abnormal cholesterol blood levels called “statins”
- Study Identifier: 833781
Contact the research team to learn more about this study.
Fields marked with asterisk (*) are required